Metraipolis › archive › dc_ff39db7a6c70
Brexpiprazole in India and the United States: A Comparative Review of Regulatory Status, Clinical Evidence, Market Access, and Evidence Gaps — Europe PMC PMID:42953479
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42953479
- DOI
- 10.7759/cureus.117032
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T08:59:11.112Z
- SHA-256 of the archived text
20cdb231e92d44cd5cf3c840e718ed681a00df506e5e0d895b33e2783dcf3f24- Stable URL of this page
https://metraipolis.com/documento/dc_ff39db7a6c70
How to cite
Brexpiprazole in India and the United States: A Comparative Review of Regulatory Status, Clinical Evidence, Market Access, and Evidence Gaps — Europe PMC PMID:42953479 — Europe PMC (en), https://europepmc.org/article/MED/42953479 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff39db7a6c70 (Metraipolis archive dc_ff39db7a6c70, sha256 20cdb231e92d44cd5cf3c840e718ed681a00df506e5e0d895b33e2783dcf3f24)
BibTeX
@misc{dcff39db7a6c70,
title = {Brexpiprazole in India and the United States: A Comparative Review of Regulatory Status, Clinical Evidence, Market Access, and Evidence Gaps — Europe PMC PMID:42953479},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42953479},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff39db7a6c70; sha256 20cdb231e92d44cd5cf3c840e718ed681a00df506e5e0d895b33e2783dcf3f24},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42953479. Agents can read the archived copy with the MCP tool read_document.